Failure of cisplatin-taxol combination therapy may be due to the dominance of cisplatin over taxol in drug resistant ovarian cancer cell lines

1998 ◽  
Vol 5 (1) ◽  
pp. 82A-82A
Author(s):  
P JUDSON ◽  
J WATSON ◽  
W FOWLERJR ◽  
J HASKILL
2016 ◽  
Vol 9 (1) ◽  
Author(s):  
Radosław Januchowski ◽  
Karolina Sterzyńska ◽  
Katarzyna Zaorska ◽  
Patrycja Sosińska ◽  
Andrzej Klejewski ◽  
...  

2016 ◽  
Vol 12 (3) ◽  
pp. 2065-2070 ◽  
Author(s):  
Jin Liu ◽  
Xiaohua Wu ◽  
Hongmei Liu ◽  
Yijuan Liang ◽  
Xinping Gao ◽  
...  

2013 ◽  
Vol 67 (3) ◽  
pp. 240-245 ◽  
Author(s):  
Radosław Januchowski ◽  
Piotr Zawierucha ◽  
Małgorzata Andrzejewska ◽  
Marcin Ruciński ◽  
Maciej Zabel

2015 ◽  
Vol 149 ◽  
pp. 45-48 ◽  
Author(s):  
Marina Stukova ◽  
Matthew D. Hall ◽  
Samantha D. Tsotsoros ◽  
James P. Madigan ◽  
Nicholas P. Farrell ◽  
...  

2020 ◽  
Vol 31 (19) ◽  
pp. 195101 ◽  
Author(s):  
Mohammad A Obeid ◽  
Siti Aisya S Gany ◽  
Alexander I Gray ◽  
Louise Young ◽  
John O Igoli ◽  
...  

Oncogene ◽  
2008 ◽  
Vol 27 (19) ◽  
pp. 2737-2745 ◽  
Author(s):  
H Sasaki ◽  
J Hayakawa ◽  
Y Terai ◽  
M Kanemura ◽  
A Tanabe-Kimura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document